BET inhibitors: Betting on improved outcomes in uterine serous carcinoma

Oncotarget. 2018 Oct 26;9(84):35470-35471. doi: 10.18632/oncotarget.26245.
No abstract available

Keywords: GS-5829; GS-626510; bromodomain and extraterminal motif proteins; endometrial cancer; uterine serous carcinoma.

Publication types

  • Editorial